
ARVN vs OVID
$ARVN vs $OVID head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ARVN vs OVID: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+8%). Split-adjusted daily closes.
- ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
- ·Only OVID beat the market over the past year, by 74.8%, while ARVN trailed the S&P 500 at +8% by 49.6%.
- ·OVID has support 34.9% below at $1.54; ARVN has no tested support within 35% under its price.
- ·ARVN is within 1.6% of resistance at $6.97, a price where it has stalled before.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
ARVN vs OVID: the quick read
- ·OVID is the larger company by market cap ($442M vs $441M).
- ·OVID has been more active on our scanner (183 vs 115 alerts in 30 days).
- ·ARVN has the smaller float (58.5M vs 176.0M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 183 and 115 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 0% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Watching ARVN or OVID? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ARVN and OVID on TheDesperateTrader.
- Is ARVN or OVID the better stock?
- "Better" depends on your goal, and these two are not alike. OVID is the larger company by market cap ($442M vs $441M). OVID has been more active on our scanner (183 vs 115 alerts in 30 days). ARVN has the smaller float (58.5M vs 176.0M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ARVN and OVID?
- The differences that matter: they are similar in size ($441M vs $442M); they trade at very different share prices ($6.86 vs $2.37); ARVN sits at 6% of its 52-week range against 61% for OVID; our scanner flagged ARVN 115 times in the last 30 days against 183 for OVID. Everything above is measured from the latest completed session and SEC filings.
- Which of ARVN and OVID is more active right now?
- Right now ARVN is at about 0.9x its normal volume and OVID is at about 0.8x, so ARVN is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is ARVN or OVID in the stronger trend?
- ARVN is below its 50-day average of $7.44 and below its 200-day average of $9.26; OVID is below its 50-day average of $2.47 and below its 200-day average of $2.43. OVID leads 4 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ARVN or OVID? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ARVN and OVID comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.